Post Description: Mankind Pharma Limited has informed its shareholders that the 35th Annual General Meeting (AGM) will be held on Tuesday, 4 August 2026 at 3:30 PM (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The Notice of the AGM and the Annual Report for FY 2025–26 will be sent via email to members whose email addresses are registered with the Company, Registrar & Share Transfer Agent (KFin Technologies Limited), or their Depository Participants (DPs). Shareholders are advised to update their email addresses and other KYC details with their respective DPs to receive all communications electronically. Members will be able to attend the AGM through VC/OAVM and cast their votes using the remote e-voting and e-voting facilities during the meeting. Detailed instructions for joining the AGM and voting will be provided in the AGM Notice. Shareholders who wish to receive a hard copy of the AGM Notice and Annual Report may submit a request to the Company via email. Contact Details: Mankind Pharma Limited Registered Office: 208, Okhla Industrial Estate, Phase II, New Delhi – 110020, India Corporate Office: 262, Okhla Industrial Estate, Phase III, New Delhi – 110020, India Phone (Registered Office): +91 11 4747 6600 Phone (Corporate Office): +91 11 4684 6700 Email: investors@mankindpharma.com Website: www.mankindpharma.com